The Cost of Diabetes in MANITOBA

Similar documents
The Cost of Diabetes in NOVA SCOTIA

The Cost of Diabetes in PRINCE EDWARD ISLAND

THE COST OF DIABETES IN ALBERTA

The Cost of Diabetes in NEWFOUNDLAND & LABRADOR

THE COST OF DIABETES IN BRITISH COLUMBIA

The Economic Benefit of Expanding Public Funding of Insulin Pumps in British Columbia

The Economic Benefit of Expanding Public Funding of Insulin Pumps in. and Labrador

THE ECONOMIC IMPACT OF OFFLOADING DEVICES FOR THE PREVENTION OF AMPUTATIONS IN BRITISH COLUMBIA

THE ECONOMIC IMPACT OF OFFLOADING DEVICES FOR THE PREVENTION OF AMPUTATIONS IN SASKATCHEWAN

Appendix B Fracture incidence and costs by province

THE ECONOMIC IMPACT OF OFFLOADING DEVICES FOR THE PREVENTION OF AMPUTATIONS IN NEW BRUNSWICK

THE ECONOMIC IMPACT OF OFFLOADING DEVICES FOR THE PREVENTION OF AMPUTATIONS IN NOVA SCOTIA

THE ECONOMIC IMPACT OF OFFLOADING DEVICES FOR THE PREVENTION OF AMPUTATIONS IN NEWFOUNDLAND AND LABRADOR

THE ECONOMIC IMPACT OF OFFLOADING DEVICES FOR THE PREVENTION OF AMPUTATIONS IN PRINCE EDWARD ISLAND

Provincial Projections of Arthritis or Rheumatism, Special Report to the Canadian Rheumatology Association

Notes for Remarks Dr. Jan Hux, President and Kimberley Hanson, Director, Federal Affairs Diabetes Canada. To the Standing Committee on Health

Estimating the economic value of reducing smoking rates in Canada to 18% and the cost of failing to achieve the 12% goal.

Diabetes in Manitoba 1989 to 2006 R E P O R T O F D I A B E T E S S U R V E I L L A N C E

Submission to Standing Committee on Health. With no leadership, Canada s diabetes crisis will continue to get worse

THE CVD CHALLENGE IN NORTHERN IRELAND. Together we can save lives and reduce NHS pressures

Epidemiological Update on Dementia, Including Alzheimer s Disease, in Manitoba:

Diabetes and Hypertension in Canada: New data from the Canadian Chronic Disease Surveillance System

The Costs of Tobacco Use in Canada, 2012.

Economic Burden of Musculoskeletal Diseases in Canada

Michigan s Diabetes Crisis: Today and Future Trends. Dr. William Rowley Institute for Alternative Futures

Cost of Injury in Canada Ontario Highlights

An Unhealthy America: The Economic Burden of Chronic Disease

We are here to help Provincial offices The Alzheimer Society works Alzheimer Society B.C. right across Canada

The Economic Burden of Hypercholesterolaemia

REPORT FROM THE CANADIAN CHRONIC DISEASE SURVEILLANCE SYSTEM:

Groupe d Analyse Économique An Analysis Group Company

IMPROVING HEALTH AND LOWERING COSTS. Benefits of pharmacist care in hypertension in Manitoba

Strong Federal Leadership to Support People With Diabetes Live to Their Full Potential

START HERE, START NOW: CROSS-SECTORAL PARTNERSHIP IN IMPROVING DEPRESSION MANAGEMENT IN PRIMARY CARE

CANNABIS IN ONTARIO S COMMUNITIES

Speaking Notes. - TB in First Nations and Inuit Communities -

Diabetes 360º. Q s and A s. Why is Diabetes Canada calling on the government to establish a national strategy for diabetes and why now?

Addiction Environmental Scan: Mapping Addictions in the Central East LHIN (CELHIN) - Defining the Gaps and Opportunities Project

Heart Disease and Stroke in New Mexico. Facts and Figures: At-A-Glance

Health technology Four strategies for the control of serogroup C meningococcal disease (CMD) were examined. These were:

Report from the National Diabetes Surveillance System:

FALL PREVENTION AND OLDER ADULTS BURDEN. February 2, 2016

Nutrition and Physical Activity Situational Analysis

Chronic Disease Summary: Nunavut (Fiscal Years )

Trends of Diabetes in Alberta

HEALTH SURVEILLANCE INDICATORS: YOUTH ORAL HEALTH. Public Health Relevance. Highlights

Data Then and Now. What do your Numbers Mean?

SUBJECT: Proclamation American Diabetes Month

The SALVEO Study Improving mental health in the workplace

Implementation plan for the systems approach to suicide prevention in NSW

Vaccines: Canadian majority believes vaccinations are effective; but two-in-five say the science isn t clear

We are here to help Provincial offices The Alzheimer Society works Alzheimer Society B.C. right across Canada

CONTRACEPTIVES SAVE LIVES

Bill Would Set Manitoba's Animal Protections Back By A

Projecting fertility by regions considering tempo-adjusted TFR, The Austrian Approach

Diabetes in New Zealand Models and Forecasts

Cost of Diabetes. Laura Keller Director State Advocacy AK CO HI ID MT ND OR SD WA WY

William W.L. Wong, PhD School of Pharmacy University of Waterloo. CADTH Symposium April 17, 2018

What is a Defendable Estimate of 0 Dementia Prevalence and Monetary Costs?

Case Study: Type 2 Diabetes Management Care Pathway

Diabetes in Manitoba: Trends among Adults

Waiting Your Turn Wait Times for Health Care in Canada, 2017 Report

Diabetes 101: A Brief Overview of Diabetes and the American Diabetes Association

Waiting Your Turn. Wait Times for Health Care in Canada, 2018 Report. by Bacchus Barua and David Jacques. with Antonia Collyer

Epilepsy Action Day at Queen s Park. December 1, 2014

Association of American Cancer Institutes

Source of effectiveness data The effectiveness data were derived from a review of completed studies and authors' assumptions.

Health Disparities Matter!

DEMENTIA IN CANADA, INCLUDING ALZHEIMER S DISEASE

Key Facts About. ASTHMA

Aussi disponible en français sous le titre : Le Diabète au Canada : Rapport du Système national de surveillance du diabète, 2009

Improving Quality of Life for Older Adults in Ontario: Issues and opportunities. Knowledge Transfer and Exchange Forum March 15, 2013 CAMH

Bill S-211: Recognizing June 19 as the Canadian Sickle Cell Awareness Day

This slide set provides an overview of the impact of type 1 and type 2 diabetes mellitus in the United States, focusing on epidemiology, costs both

Towards a Provincial Strategy

CORPORATE. Work-Fit INJURY SOLUTIONS. Helping Workers Get Better And Stay Better

Tobacco, Development, and the Canadian Experience

Cost-effectiveness in FASD prevention. Egon Jonsson, Institute of Health Economics, Edmonton, Alberta, Canada

Financing the Response to AIDS in Low- and Middle- Income Countries: International Assistance from Donor Governments in 2011

Influenza & Other Modelling Activities at the Public Health Agency of Canada (PHAC)

Proposed Strategy for Epilepsy Care in Ontario

Lessons from the Development of a Canadian National System of Surveillance

APPLICATION OF COST/BENEFIT ANALYSIS TO

HEALTH PROMOTION AND CHRONIC DISEASE PREVENTION PROGRAM OREGON STATE OF THE HEART AND STROKE REPORT 2001 PREPARED BY.

Economic Study Estimates Meth Abuse Costs the U.S. $23.4 Billion

Cost-benefit analysis of first-void urine Chlamydia trachomatis screening program Paavonen J, Puolakkainen M, Paukku M, Sintonen H

Supports that can help with the high financial cost of diabetes. Presentation to Type 1 Conference September 2018

Diabetes in New Brunswick

Cardiovascular disease: Beat the Heart Disease and feel a Healthy Beat Therapeutic capacity presentation series V1.0.

A Labour Market Study of Occupational Therapists in Saskatchewan

OVAC FY 2017 Appropriations Requests

Healthy People, Healthy Communities

ASSESSING THE VALUE OF BIOPHARMACEUTICAL INNOVATION IN KEY THERAPY AREAS IN MIDDLE-INCOME COUNTRIES

COSTS OF HEALTH SERVICES UTILIZATION OF PEOPLE WITH FETAL ALCOHOL SPECTRUM DISORDER BY SEX AND AGE GROUP IN ALBERTA, CANADA

PROFILE AND PROJECTION OF DRUG OFFENCES IN CANADA. By Kwing Hung, Ph.D. Nathalie L. Quann, M.A.

Measuring and Mapping the Rheumatology Workforce in Canada An update for: Royal College- National Speciality Societies Human Resource for Health

The DIABETES CHALLENGE IN PAKISTAN FIFTH NATIONAL ACTION PLAN

Comprehensive, Conservative Care Model: ChiroFirst Study

Consultation on Australian Medical Research and Innovation Priorities for

Canadian Adult and Youth Opinions on the Sizing of Health Warning Messages HC H /001/CB

Transcription:

The Cost of Diabetes in MANITOBA

The Cost of Diabetes in Manitoba The Manitoba Diabetes Cost Model 1 In 2009, the Canadian Diabetes Association commissioned a report, An Economic Tsunami: the Cost of Diabetes in Canada, to determine the cost of diabetes in Canada, including the impact of lost productivity on the economy. The report also evaluated the potential benefits of initiatives designed to delay or prevent the onset of type 2 diabetes and reduce the occurrence and severity of complications arising from the disease. The diabetes cost model used in the 2009 report has since been adapted to provide an analysis of the costs of diabetes at provincial levels. The findings in this report are the preliminary findings concerning the costs of diabetes in Manitoba derived through the Manitoba Diabetes Cost Model. This is one of a series of reports issued on diabetes at a provincial level. The Association will continue to roll-out diabetes cost models across Canada. 1 The Manitoba Diabetes Cost Model was created for the Association by the Centre for Spatial Economics based on the Canadian Diabetes Cost Model developed by Informetrica Limited and made possible by an unrestricted educational grant provided by Novo Nordisk Canada Inc. The two main sources of data used for the estimate and forecasts come from the National Diabetes Surveillance System (NDSS) and Health Canada s study the Economic Burden of Illness in Canada (EBIC). The Model aimed to integrate the administrative prevalence and incidence estimates from NDSS with the economic cost estimates from EBIC. The Model supports analysis of the sensitivity of the prevalence and cost estimates to changes in demographic data, incidence and mortality rates by age and sex, and the average annual number of net general practitioner and specialist visits by people with diabetes. Assumptions made in this model are conservative and may understate the prevalence and cost of diabetes in the future, rather than to overstate it.

The Prevalence of Diabetes in Manitoba The Manitoba Diabetes Cost Model estimates 1 that 94,000 people in Manitoba have been diagnosed with type 1 or type 2 diabetes in 2010 representing approximately 7.6% of the population. This number is expected to increase by 45,000 over the next decade to 139,000 or 10.1% of the population of Manitoba. Source: Manitoba Diabetes Cost Model Diabetes in Manitoba (Table 1) 2000 2010 2020 Persons with diabetes (left axis) 53 94 139 Share of the population (right axis) 4.5% 7.6% 10.1% 1 The estimates provided in this report include the most current data available from all sources but should be viewed as preliminary and will be subject to revision based on continuing research and more complete data.

The Economic Burden of Diabetes in Manitoba The economic burden of diabetes in Manitoba is estimated to be $498 million in 2010 (measured in 2009 dollars). This cost is expected to increase by 28% over the next decade to $639 million by 2020. Source: Manitoba Diabetes Cost Model Cost of Diabetes in Manitoba In Millions of 2009 Dollars (Table 2) 2000 2010 2020 Direct costs 48 86 126 Indirect costs 292 412 514

The direct costs of diabetes which accounts for17% of the total cost of the $498 million in 2010 - are led by hospitalization costs. Indirect mortality and disability costs account for 83% of the total cost attributed to diabetes by the Diabetes Cost Model. Source: Manitoba Diabetes Cost Model Economic Costs of Diabetes in Manitoba in Millions of 2009 Dollars (Table 3) 2000 2010 2020 Direct Hospitalization 22 40 58 Net CVD Hospitalization 4 6 10 Net Doctor Visits: General Practitioner 5 8 12 Net Doctor Visits: Specialist 6 11 16 Drugs/medications for Diabetes 12 21 30 Net Mortality 245 327 397 Long-Term Disability 47 85 117 Total 340 498 639

The Factors Driving Diabetes Prevalence and Costs in Manitoba Over the next decade, population growth, an aging population, rising incidence rates and declining mortality rates will be responsible, in part, for the 45,000 net increase (a 47% rise) of people diagnosed with diabetes in Manitoba. Nearly three quarters of the increase is, however, locked-in based on the prevalence of diabetes and the province s current demographic structure due to the number of net new people diagnosed with diabetes in Manitoba each year. These same factors are also responsible for the projected $141 million increase in costs over the decade. While declining mortality rates for persons with diabetes increases the prevalence of the disease over the period, it also decreases the cost of the disease associated with premature mortality. Source: Manitoba Diabetes Cost Model

Source: Manitoba Diabetes Cost Model

About the Canadian Diabetes Association Today, more than nine million Canadians live with diabetes or prediabetes. Across the country, the Canadian Diabetes Association is leading the fight against diabetes by helping people with diabetes live healthy lives while we work to find a cure. Our community-based network of supporters help us provide education and services to people living with diabetes, advocate for our cause, break ground towards a cure and translate research into practical applications. For more information, please visit diabetes.ca or call 1-800-BANTING (226-8464).